POU3F3 and melanoma: miR-650 also contributes to drug resistance, such as by upregulating dacarbazine (DTIC) resistance in melanoma through the lncRNA POU3F3/miR-650/MGMT (methylguanine-DNA-methyltransferase) axis [19], which turns miR-650 into a potential target for cancer treatment.